Patents Assigned to DOKNIP BIOPHARM CO.
  • Pharmaceutical composition comprising attenuated strains and use thereof
    Patent number: 11135278
    Abstract: Provided is a pharmaceutical composition including attenuated Streptococcus pneumoniae strains, and a method thereof for prevention or treatment of inflammatory diseases, respiratory viral infections, bacterial infectious diseases, or allergic diseases.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: October 5, 2021
    Assignee: DOKNIP BIOPHARM CO.
    Inventors: Dong-Kwon Rhee, Seung-Han Seon, Bo-Gyung Kim